Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon

Immune checkpoint inhibitor (ICI)‐induced immune‐related adverse events (irAEs) may affect almost any organ system and occur at any point during therapy. Autoantibody analysis may provide insight into the mechanism, nature, and timing of these events. We report a case of ICI‐induced late‐onset Rayna...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Shaheen, von Itzstein, Mitchell S., Lu, Rong, Bermas, Bonnie L., Karp, David R., Khan, Saad A., Fattah, Farjana J., Park, Jason Y., Saltarski, Jessica M., Gloria‐McCutchen, Yvonne, Xie, Yang, Li, Quan‐Zhen, Wakeland, Edward K., Gerber, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Immune‐Related Adverse Events
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216445/
https://www.ncbi.nlm.nih.gov/pubmed/32167195
http://dx.doi.org/10.1634/theoncologist.2019-0666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216445/
https://www.ncbi.nlm.nih.gov/pubmed/32167195
http://dx.doi.org/10.1634/theoncologist.2019-0666

Ejemplares similares